{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:24:20Z","timestamp":1793139860357,"version":"4.5.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe two rare occurrences of acute toxic maculopathy, specifically Intracameral Cefuroxime Ocular Toxic Syndrome (ICOTS), following uncomplicated posterior-chamber toric phakic implantable collamer lens (TICL) surgery despite the administration of a standard dosage of cefuroxime.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This case report identified two patients from a clinical volume of 1,590 eyes treated between 2021 and 2024. Inclusion criteria consisted of patients undergoing bilateral TICL implantation with intracameral cefuroxime who presented with unexpected visual disturbances on postoperative day 1. To isolate cefuroxime as the primary toxic factor, exclusion criteria included systemic comorbidities (such as diabetes mellitus), pre-existing ocular pathologies (including uveitis, macular degeneration, or prior retinal detachment), history of prostaglandin analog use, or baseline structural abnormalities on preoperative optical coherence tomography (OCT). Clinical evaluation included UDVA, BCVA, and SD-OCT imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two female patients (aged 29 and 32) underwent bilateral TICL surgery with 0.1 mL of 10 g\/L intracameral cefuroxime administered at the conclusion of the procedure. On postoperative day 1, both patients presented with unilateral vision loss (BCVA 20\/32 and 20\/80, respectively) and reported dim or distorted vision. SD-OCT revealed macular edema and subretinal fluid (SRF). Following conventional postoperative treatment with topical steroids and nonsteroidal anti-inflammatory drugs, complete absorption of SRF was achieved within two weeks to one month, and BCVA improved to 20\/16 and 20\/20, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While intracameral cefuroxime is a highly effective prophylactic against endophthalmitis, it may cause sporadic toxic maculopathy even at standard doses during ICL surgery. Unlike typical post-cataract inflammatory edema, ICOTS presents acutely on day 1. Surgeons should maintain a high index of suspicion and utilize early OCT imaging for unexpected postoperative visual disturbances.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2026.1778421","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:25:58Z","timestamp":1772688358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Maculopathy following standard dose intracameral cefuroxime injection during ICL surgery"],"prefix":"10.3389","volume":"6","author":[{"given":"Zhenlin","family":"Lin","sequence":"first","affiliation":[{"name":"Fuzhou Aier Eye Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[{"name":"Fuzhou Aier Eye Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deli","family":"Li","sequence":"additional","affiliation":[{"name":"Ningde Aier Eye Hospital","place":["Ningde, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Yi","sequence":"additional","affiliation":[{"name":"Fuzhou Aier Eye Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingning","family":"Weng","sequence":"additional","affiliation":[{"name":"Fuzhou Aier Eye Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2008.12.027","article-title":"Endophthalmitis rates after implantation of the intraocular Collamer lens: survey of users between 1998 and 2006","volume":"35","author":"Allan","year":"2009","journal-title":"J Cataract Refr Surg"},{"key":"B2","article-title":"Chinese expert consensus on posterior chamber phakic intraocular lens implantation (2019)","volume":"55","year":"2019","journal-title":"Chin J Ophthalmol"},{"key":"B3","unstructured":"ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions 2013[EB\/OL]\n          \n          \n            \n              Barry\n              P\n            \n            \n              Cordov\u00e9s\n              L\n            \n            \n              Gardner\n              S"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2014.10.010","article-title":"Intracameral antibiotics: Safety, efficacy, and preparation","volume":"40","author":"Braga-Mele","year":"2014","journal-title":"J Cataract Refr Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2004.10.074","article-title":"Macular thickness after cataract surgery with intracameral cefuroxime","volume":"31","author":"Gupta","year":"2005","journal-title":"J Cataract Refr Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-025-01137-8","article-title":"Structural and functional insight into intracameral cefuroxime ocular toxic syndrome (ICOTS) in eyes with disrupted intraocular barrier","volume":"14","author":"Cusumano","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.oftal.2016.03.009","article-title":"Macular oedema after uncomplicated cataract surgery. Possible relationship with the volume of intracameral cefuroxime","volume":"92","author":"Gim\u00e9nez-de-la-Linde","year":"2016","journal-title":"Arch Soc Esp Oftalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ajo.2013.10.018","article-title":"Hemorrhagic retinal infarction due to inadvertent overdose of cefuroxime in cases of complicated cataract surgery: retrospective case series","volume":"157","author":"\u00c7ift\u00e7i","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftale.2020.12.011","article-title":"Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery","volume":"96","author":"D\u00edez-\u00c1lvarez","year":"2021","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2011.03.032","article-title":"Macular infarction after inadvertent intracameral cefuroxime","volume":"37","author":"Qureshi","year":"2011","journal-title":"J Cataract Refr Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000437013","article-title":"Postsurgical cystoid macular edema following posterior chamber toric phakic intraocular lens implantation surgery: A case report","volume":"6","author":"Canan","year":"2015","journal-title":"Case Rep Ophthalmol"},{"key":"B12","article-title":"Myopia and inflammation","volume":"6","author":"Herbort","year":"2011","journal-title":"J Ophthal Vis Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00417-015-3000-8","article-title":"Longitudinal analysis of the structural pattern of pseudophakic cystoid macular edema using multimodal imaging","volume":"254","author":"Sigler","year":"2015","journal-title":"Graef Arch Clin Exp"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31821e2225","article-title":"Spectral-domain optical coherence tomography in Irvine-Gass syndrome","volume":"32","author":"Minnella","year":"2012","journal-title":"Retina-J Ret Vit Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10633-014-9465-7","article-title":"Retinal toxicity after intracameral use of a standard dose of cefuroxime during cataract surgery","volume":"130","author":"Faure","year":"2014","journal-title":"Doc Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000455280","article-title":"Postsurgical cystoid macular edema","volume":"58","author":"Zur","year":"2017","journal-title":"Dev Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.001","article-title":"Risk factors and incidence of macular edema after cataract surgery: A database study of 81984 eyes","volume":"123","author":"Chu","year":"2015","journal-title":"Ophthalmology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-014-0022-z","article-title":"Pharmacokinetics of intravitreal antibiotics in endophthalmitis","volume":"4","author":"Radhika","year":"2014","journal-title":"J Ophthalmic Inflammation Infect"},{"key":"B19","article-title":"Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys","volume":"24","author":"Barza","year":"1983","journal-title":"Invest Ophth Vis Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1998.14.555","article-title":"Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes","volume":"14","author":"Coco","year":"1998","journal-title":"J Ocul Pharmacol Th"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000714","article-title":"Drug-induced maculopathy","volume":"31","author":"Khan","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2020.1734817","article-title":"Incidence of cystoid macular oedema with intracameral cephalosporin or vancomycin in cataract surgery","volume":"39","author":"Adeli","year":"2020","journal-title":"Cutan Ocul Toxicol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jcrs.2017.09.031","article-title":"Toxic retinopathy after phacoemulsification when the cefuroxime dilution is correct","volume":"44","author":"Zuo","year":"2018","journal-title":"J Cataract Refr Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8053","article-title":"Physiological and toxicological effects of cefuroxime on the albino rabbit retina","volume":"53","author":"Shahar","year":"2012","journal-title":"Invest Ophth Vis Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000228","article-title":"Differential diagnosis of macular edema of different pathophysiologic origins by spectral domain optical coherence tomography","volume":"34","author":"Munk","year":"2014","journal-title":"Retina-J Ret Vit Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2013.06.007","article-title":"Early macular edema after phacoemulsification and suspected overdose of cefuroxime: report of six cases","volume":"37","author":"Le D\u00fb.","year":"2014","journal-title":"J Fr Ophtalmol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e00043","DOI":"10.1097\/j.jcro.0000000000000043","article-title":"Unilateral acute macular edema with serous macular detachment after bilateral phacoemulsification","volume":"9","author":"Burridge","year":"2021","journal-title":"JCRS Online Case Rep"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1778421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:26:00Z","timestamp":1772688360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1778421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":27,"alternative-id":["10.3389\/fopht.2026.1778421"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2026.1778421","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"1778421"}}